Performed measurements were shown the similar as for rectum detector angular dependence of IN-VIVO bladder detector readings for Ir-192 radiation. Results make obvious that for more accurate probe calibration the angular testing of its sensitivity should be done. Angular and off-axial components of the diode response should be identified. The best angular ranges for performing the longterm reproducibility calibrations should be recognized and appropriate marking on the catheter surface should be done. The fluoroscopic images, which are taken during treatment planning procedure, allow to find out the angle of the detector to direction of radiation coming from the radiation source and based on that appropriate correction factor can be estimated. As the final result of all these actions it can be achieved more agreement between planning treatment dose calculations and IN-VIVO measurements.
EP-1138
Preliminary results of a new external quality control protocol for stereotactic CyberknifeAE treatments. V. Marchesi 1 , L. Guinement 1 , A. Veres 2 , T. Lacornerie 3 , D. Peiffert 4 , A. Noel 5 1 Centre Alexis Vautrin, Department of Radiation Physics, Nancy Cedex, France 2 Villejuif, France 3 Centre Oscar Lambret, Department of Radiation Physics, Lille, France 4 Centre Alexis Vautrin, Department of Radiation Therapy, Nancy, France 5 Université de Lorraine-CNRS, CRAN UMR 7039, Nancy, France Purpose/Objective: To develop a protocol (irradiation procedure, action levels) for an external quality control of stereotactic beams of Cyberknife® with Equal-Estro laboratory. These preliminary studies involved seven French institutions. Materials and Methods: Equal-Estro provided a cubic waterequivalent plastic phantom (so-called'mini-cube') containing four thermoluminescent detectors, TLDs, (TLD-100, Harshaw) and three radiochromic films (Gafchromic EBT2). This phantom was designed to be inserted in ananthropomorphic head phantom used to perform endto-end quality controls. The phantom had to be irradiated according to a protocol describing a target volume in which three TLDs were encompassed with a 5mm isotropic margin, and one organ at risk represented by the fourth TLD. A maximum dose of 4.1Gy was prescribed to the target volume. After irradiation in a single fraction, the 'mini-cube' phantom was returned to Equal-Estro laboratory to be analyzed and measured doses were compared to calculated doses. Absolute dose deviations were evaluated using the TLDs and gammaindex analyses were performed on films. A preliminary study was performed to determine the statistical accuracy and the most appropriate action levels to be applied to all tests. Results: Intrinsic TLD dose measurement on Cyberknife beams is reliable as reproducibility was of about 1.7% (1 SD) for a single beam. Dose deviations were lower than 5% for PTV-TLDs in most of the tested centers but larger deviations were observed on the OAR-TLD in some institutions. Investigations performed subsequently have identified the non homogeneous dose distribution onthe TLD to be the main cause of measured deviations. Analyses of different gamma-index criteria allowed choosing the 5%/2mm as the most appropriate tolerance level for gamma index tests, which is consistent with the film analysis procedure uncertainty (mostly due to the matching uncertainty of dose distributions). Conclusions: An accuracy of 5% can be achieved if dose inhomogeneity in TLDs volumes is reduced in the planning process. The final version of the planning protocol will include the use of a PTV and a PRV around the TLDs, with constraints on dose homogeneity on the DVHs. This work will be followed by a second round of irradiations using the improved version of the procedure. Purpose/Objective: The aim of this work is to characterize the Dosi-Secure® detector for in vivo dosimetry in High Energy photon beams. Measurements are first performed on phantom and then on patients to determine the level of accuracy of the device in clinical use. Materials and Methods: TheDosi-Secure® system consists of a wireless and passive detector (Dosi-Patch®), a tactile reader (Dosi-Pad®) and an associated software. This system ensures the traceability of in vivo dosimetry for each patient during the radiotherapy session. The detector is based on a specific PMOS technology. A build-up cap is incorporated to allow measurements at the maximum depth dose (entrance dose). The dosimeters are calibrated by the manufacturer; there have no embedded correction factors. The dosimeters are placed on the surface of a water equivalent slab phantom and irradiated with 8MV and 25MV photon beams. The influence of the variation of different parameters on detector response is evaluated: field size (open and wedged beams), SSD and angular incidence. All 2nd ESTRO Forum 2013 S427 the measurements were compared to the dose measured with a cylindrical ionization chamber placed at the maximum depth dose. Repeatability over 10 measurements is also investigated. The device accuracy in clinical use is assessed by performing measurements of clinical beams on anthropomorphic phantoms (8-25MV) and on patients (25MV). Results arecompared with entrance dose obtained with the TPS. Results: Dosi-Patch® has the same behavior as the ionization chamber for varying field size with and without wedge (EDW 60°). Agreement is good with a deviation less than 5% for both energies. There is no angular dependence in both energies (in the range ±30°). Dosi-Patch® overestimates the dose for short SSD. The deviation increases up to 7.5% (8MV) and 4.9% (25MV) as the SSD decreases. This effect is more pronounced for 8MV than 25MV. This suggests a need for SSD correction for 8MV. The measurements repeatability is correct with a coefficient of variation of 0.4% for 8MV and 0.44% for 25MV. Results of clinical beams measurements on phantom and on patients are presented in figure1. 90% of the measurements on phantom for 8MV (with SSD correction) have a deviation ≤ 5% compared to the TPS. For 25MV photon beam, 83% of the measurements on phantom and 84% of the measurements on patients have a deviation ≤ 5%. For all measurements with a deviation more than ± 5%, the difference in absolute dose is less than 10 cGy, which is suitable for an in vivo dosimetry use.
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Figure 1:Distribution of the deviations between Dosi-Patch® and TPS measurements (n=20,29,19 for Phantom 8MV,25MV and Patients 25MV respectively)
Conclusions: Dosi-Secure® is an accurate detector for in vivo dosimetry in 8MV and 25MV photon beams. There is no need for correction factors for varying field size and angle. However, the use of correction factor for SSD improves the accuracy of the detector. Measurements on patients with SSD correction factor in 8MV photon beams are currently implemented.
EP-1140 EPID based MLC calibrations require extra buildup to prevent systematic errors.
M. van het Loo 1 , K.L. Pasma 1 1
Institute for Radiation Oncology Arnhem, Department of Radiation Physics, Arnhem, The Netherlands
Purpose/Objective: For multi leaf collimator (MLC) calibration Electronic Portal Image Devices (EPIDs) are replacing film based methods. A systematic error can be introduced if the field size measured with the EPID differs from the field size of the reference field size. The reference field size (at a depth of 10 cm in water and at a source distance of 100 cm) is measured using radiochromic film (Gafchromatic EBT2), since its electron density is close to that of water. We observed a small systematic deviation in the field size measured with an EPID compared to film. The aim of this study is to minimize this systematic error in the field size. Materials and Methods: All measurements are performed on an Axesse linac (Elekta, Stockholm, Sweden) equipped with an IviewGT EPID. This EPID basically consists of a 1 mm thick copper plate with a scintillator screen. The flat panel detector has a size of 40.96 × 40.96 cm 2 and has 1024 2 pixels. The source to scintillator distance is 159.7 cm. The resulting pixel size at isocenter is 0.251 mm. The field size is defined as the width at half the dose of the field center. All measurements are performed 10 times for 6 MV photon beams. The first part of this study consist of measuring a nominal field size of 4 x 4 cm². EPID measurements are performed with additional plates of polymethylmethacrylaat (PMMA) on top of the copper plate of the EPID. The thickness of PMMA is converted into Water Equivalent Thickness (WET) using a factor 1.137. The second part consists of leaf calibration measurements. The leaf calibration consists of a strip test with nine adjacent segments of 2 cm wide, separated by 1 mm and exposed on the EPID. Normally the leaf calibration is performed with the standard EPID configuration. In this study the leaf calibration is also performed using an additional build-up of 2.5 mm copper (WET ~ 2.2 cm) and with an additional build-up of PMMA with a WET of 8.5 cm. Results: The effect of additional build-up on the field size is depicted in Figure 1 . The build-up is expressed as water equivalent thickness added on the EPID. Figure 1 . The effect of additional build-up on the field size. The field size measured with EPID without additional build-up is approximately 0.2 mm smaller than the reference field size. Performing a leaf calibration adding 2.5 mm copper yields a field size close to the reference field size. Conclusions: The leaf calibration with an unmodified EPID causes a systematic deviation of the measured field size of approximately 0.2 mm. Using an additional build-up of 2.5 mm copper on the EPID the measured field size is in excellent agreement with the expected field size at reference depth in water. Adding this extra copper has no clinical relevant effect on image quality (van Elmpt et al., 2008) . This modification is therefore recommended for all EPIDs used for MLC calibrations. 
EP-1141
ASL Esine, Radiation Oncology, Esine, Italy
Purpose/Objective: The daily quality controls (QC) of Intensity Modulated Radiotherapy Treatments (IMRT) are part ofthe radiotherapy chain, leading to a significant drain of human resources. The aim of this study is determine whether they are still necessary for every single patient. In our clinical routine we perform two measurements prior to the first fraction of treatment. One point dose measurement and one planar dose measurements by matrix of ionization chambers. We analyzed the results of pre-treatment measurement checks to quantify the occurrence of results out of tolerance, and analyze the causes of failure. Materials and Methods: We analyzed 544 pre-planning checks performed in 19 months of Tomotherapy activity. All analyzed measurements were performed with an Exradin micro-ionization chamber (A1SL), a water equivalent cheese phantom provided by the Tomotherapy Accuray™. Each treatment plan is re-calculated on a CT image of cheese phantom with the ion chamber to determinate the dose in a RT treatment high dose point. All measurements were corrected for daily output variation. We analyzed our measurements comparing them to calculated dose. The tolerance for this test is 3% of measured versus calculated dose. Results: Figure 1 reports the absolute frequency of dose difference results
